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ARTICLE
Clinical Study
Addition of ultrasound to mammography in the case of dense
breast tissue: systematic review and meta-analysis
Matejka Rebolj 1, Valentina Assi2, Adam Brentnall1, Dharmishta Parmar1 and Stephen W. Duffy1
BACKGROUND: Mammography is less effective in detecting cancer in dense than in fatty breasts.
METHODS: We undertook a systematic search in PubMed to identify studies on women with dense breasts who underwent
screening with mammography supplemented with ultrasound. A meta-analysis was undertaken on the proportion of cancers
detected only by ultrasound, out of all screen-detected cancers, and the proportion of women with negative mammography who
were referred for assessment following ultrasound screening.
RESULTS: Twenty-nine studies satisfied our inclusion criteria. The proportion of total cancers detected only by ultrasound was 0.29
(95% CI: 0.27–0.31), consistent with an approximately 40% increase in the detection of cancers compared to mammography. In the
studied populations, this translated into an additional 3.8 (95% CI: 3.4–4.2) screen-detected cases per 1000 mammography-negative
women. About 13% (32/248) of cancers were in situ from 17 studies with information on this subgroup. Ultrasound approximately
doubled the referral for assessment in three studies with these data.
CONCLUSIONS: Studies have consistently shown an increased detection of breast cancer by supplementary ultrasound screening.
An inclusion of supplementary ultrasound into routine screening will need to consider the availability of ultrasound and diagnostic
assessment capacities.
British Journal of Cancer https://doi.org/10.1038/s41416-018-0080-3
INTRODUCTION
Since the publication of the randomised trials showing a
significant breast cancer mortality reduction with the offer of
breast screening with mammography, large numbers of screening
programmes have been instituted worldwide.1–4 These pro-
grammes are estimated to prevent substantial numbers of breast
cancer deaths2–4 and standards have been developed to monitor
and maintain the quality of the services.5,6
One area where there is room for improvement is the lower
sensitivity of mammographic screening in women with dense
breast tissue.7 Since the introduction of legislation in the USA
requiring disclosure of mammographic density to screenees, there
has been considerable international interest in potential variation
in screening regimen based on breast density.8,9 Possible tactics
include increased frequency of screening in the case of dense
breast tissue,10 but in both the USA and Europe, there is much
interest in supplemental imaging in addition to mammogra-
phy.8,11,12 The latter option seems logical, since if a test is shown
to be less sensitive in a population, using a different test may be
more effective than applying the same test more frequently.
While there is strong evidence that magnetic resonance
imaging confers a substantial improvement in sensitivity, particu-
larly in high-risk groups,13 it remains an expensive option and
requires considerable commitment from the screenee.14 There is
therefore interest in the use of ultrasound, hand-held or
automatic, in addition to mammography in the case of dense
breast tissue.12,15 A policy decision regarding the use of adjunctive
ultrasound for screening in dense breasts would need to be
informed by evidence on the increase in breast cancer detection
capability, the resource and human costs of the ultrasound
imaging, and the resource and human costs of further diagnostic
workup as a result of positive ultrasound findings. A decision
would also need to be made as to how to define the dense tissue
subgroup of the population, as there are many methods of
measuring breast density.7
In this paper, we review the published literature on the use of
ultrasound in addition to mammography in screening women
with dense breast tissue. We summarise in quantitative terms the
likely benefit in terms of increased breast cancer detection, and
the effect on the increased diagnostic activity, specifically in terms
of recall rates for assessment. The benefit and the required
diagnostic activity are further discussed in the context of a routine
mammography screening service such as the one implemented
by the NHS Breast Screening Programme.
MATERIALS AND METHODS
Inclusion criteria and PICOS terms
Methods and inclusion criteria were specified in advance,
although the protocol was not registered. Studies had to report
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data on breast cancers, either invasive or ductal carcinomas in situ
(DCIS), detected in consecutive or randomly selected women with
dense breasts. No limitation was imposed for the women’s age,
the breast density classification system used in the study, or the
proportion of the included women who had additional breast
cancer risk factors. These women were screened with mammo-
graphy and had undergone supplemental screening with ultra-
sound, the latter at least in case mammography was negative.
As the focus was on the detection at screening, we excluded
studies of women with symptoms, and any cancers diagnosed
after normal screening tests (i.e., interval cancers). We also
excluded studies where women receiving mammography screen-
ing were different from women receiving ultrasound examina-
tions, or where breast cancers in dense breasts were not reported
separately from those in fatty breasts. Studies published before
year 2000 were excluded as the ultrasound imaging technology
has developed considerably in terms of quality in recent decades.
No language restrictions were imposed. In case of duplicate
publications, the report with the most complete data was included
in the meta-analysis.
Literature search
The search was developed by D.P. and S.D. The investigators
searched PubMed on 29 June 2016 using the following criteria:
[ultrasound AND breast AND screening AND (“density” OR
“dense”)], limited to publication date from 1 January 2000 onward.
The search was updated on 26 July 2017 to identify any new
publications since 1 June 2016. All analyses were based on
published data, but study authors were contacted, if necessary, for
further clarifications that concerned study eligibility.
Two authors (S.D., M.R.) independently screened the abstracts of
all retrieved records, with a subgroup also screened by D.P.
Reference lists of all reviews and other types of secondary
publications (including letters, news items, etc.) were checked for
additional primary data. Two authors (either S.D. or V.A., and M.R.)
independently assessed full texts for inclusion and retrieved
information on study and population characteristics and on
screening outcomes into pre-specified tables. Two authors (V.A.,
M.R.) independently evaluated study quality following the Quality
Assessment of Diagnostic Accuracy Studies (QUADAS) Version 2
evaluation tool.16 Any discrepancies were resolved through
consensus.
Statistical analysis
The primary aim was to measure the relative increase in cancer
detection from supplemental ultrasound screening. For this
purpose, we considered those studies reporting the number of
cancers detected only by ultrasound (r) and the total number of
cancers detected (n, by mammography and ultrasound supple-
mental screening). A meta-analysis was undertaken on the
proportion p= r/n detected only by ultrasound. This may be
related to the percentage increase through q= r/(n−r)=
(p−1−1)−1. To help stabilise the binomial variance, an arcsin
(r/n)0.5 transformation was applied,17 on which scale standard
fixed-effect (FE) (inverse variance) and random-effect (RE) meta-
analysis estimates were obtained.18 Results were back-
transformed to proportions for presentation; exact confidence
intervals for individual studies were presented in forest plots.
Evidence for departure from the FEs model was assessed using the
I2 statistic (ratio of between-study variance to total variance).
Funnel plot is a standard visual instrument examining the
relationship between the effect estimate and a measure of study
precision in order to investigate potential reporting or other
biases.19 As study sizes and standard errors were not reported for
all studies, we examined p against total number of cancers on a
square root scale, centred around an overall p from the total
number of cancer detected only by ultrasound divided by total
cancers. Prediction intervals were obtained from the inverse
binomial transformation, and plotted using a loess smoother to
aid interpretation.
The secondary aim was to determine the additional detection of
breast cancer and referrals for assessment per 1000 women with
mammography negative results. A meta-analysis was undertaken
on the absolute numbers of detected cancers and referrals owing
only to ultrasound examinations. The 95% confidence intervals
were calculated as exact binomial intervals.
Furthermore, we investigated the associations between the
variables of interest using Pearson correlation coefficients (ρ)
weighted by study size (number of all screened women or number
of women with negative mammography).
In the studies where the same women underwent several
screening rounds, the unit of observation was an individual
screening episode. There were no pre-defined sub-groups.
Analysis was undertaken using the meta and weights packages
for statistical software R 3.4.1.20–22
RESULTS
Search results
The original search identified 716 unique records (Fig. 1). The
updated search identified 174 records. In total, 29 studies satisfied
our inclusion criteria. Although several reviews had been
published,23,24 no previous meta-analysis could be identified.
In total, 13 studies compared mammography and supplemental
ultrasound screening to screening using mammography alone in
the same women.12,15,25–35 Ten of these studies were undertaken
in general populations of women with dense breasts15,25–31,34,35
and three studies were in women with additional risk factors12,32,33
(Table 1). An additional 16 studies were undertaken using
ultrasound in women with negative mammography,8,36–50 of
which one46 was in women with additional risk factors. Ten
studies were undertaken in the USA,8,15,27,40,44–47,49,50 six in
Italy,25,30,31,33,36,39 five in South Korea,34,37,41,43,48 and one each in
China,26 Israel,38 Singapore,42 Austria,28 Thailand,29 Germany32 and
Sweden,35 and one study was undertaken in multiple countries
(USA, Argentina, Canada).12 All studies with reported data on age
also included women below 50 years, but age breakdowns for the
studied outcomes were not reported systematically. Twelve
studies reported women undergoing a clinical breast examination
prior to an ultrasound examination8,27,30,32–34,38–42,46 (Supplemen-
tary Table 1). As reported, mammography was read with knowl-
edge of ultrasound imaging in three studies29,37,39 but in another
three studies the interpretation of ultrasound imaging was
blinded to mammographic findings.12,32,33 Screening was under-
taken either in organised programmes or in other settings, e.g.
allowing women and/or their doctors to self-refer.
Breast density was defined predominantly using the American
College of Radiology’s Breast Imaging–Reporting and Data System
(BI–RADS). Four studies defined dense breasts as BI–RADS
categories 2 to 4 (i.e., including breasts with ≥25% fibroglandular
tissue),27–29,38 whereas 24 studies defined dense breasts as
BI–RADS 3 or 4 (i.e. including breasts with ≥50% fibroglandular
tissue).8,12,15,25,26,30–32,34–37,39–50 One study reported classifying
breasts as dense if fibroglandular tissue occupied >50% of the
breast as a mean of two mammographic views but did not
explicitly explain the classification system.33
Extra detection of breast cancers
The main analysis included 1692 breast cancers detected in
12 studies reporting detection of breast cancer in the entire
screening population, of which 494 (29%) were detected only by
supplemental ultrasound (a relative detection rate of 141%, with
the increased detection calculated as 494/(1692–494), see
Statistical Analysis and Table 2). The overall FE estimate of the
proportion of total cancers detected by ultrasound was 0.29 (95%
CI: 0.27–0.31); the estimate of an RE distribution mean was 0.31
Ultrasound screening for women with dense breasts














(95% CI: 0.25–0.37). Both measures were very close despite
substantial between-study variation (I2= 81% (95% CI: 68–89%);
Fig. 2a). The results suggest that detection rates are on average
increased by approximately 40% with supplemental ultrasound
compared to mammography alone. In the only six studies
reporting detection separately for DCIS and invasive cases, DCIS
cases represented only a smaller proportion of the cases detected
by ultrasound. The FE estimate, almost identical to the RE
estimate, was 0.10 (95% CI: 0.05–0.16), consistent with an increase
in the detection of 11%. The study by Brancato and colleagues30
was not included as the total number of cancers in women
undergoing supplemental ultrasound screening was unknown; a
sensitivity analysis where it was included did not materially alter
the results.
A funnel plot is shown in Fig. 3. There is a small suggestion of
publication bias due to the two small studies reporting large
effects, but this was tempered a little by a couple of larger studies
with smaller effect sizes.
Subgroups were investigated to assess whether the variation
between studies could be explained by (1) studies that included
BI–RADS density 2 as ‘dense’; (2) study year (a proxy for digital vs.
film mammography); or (3) extent of other risk factors. Although
Records identified through the original
database search
(N=716)







Not (only) screening or other
selections (N=25)
Results not reported by breast density
(N=22)
Mammography and/or ultrasound
results not reported separately, or in
different women (N=11)
Duplicate publications (N=5)
Other aspects of using ultrasound
(N=2)
No cases detected by either
mammography or ultrasound (N=2)
Not a full publication (N=1)





































Fig. 1 PRISMA flow diagram of study selection. Baseline search undertaken on 29 June 2016. Update search undertaken on 26 July 2017.
a Reference lists of reviews and similar publications were examined for any additional studies reporting primary data. The latter studies were
included in the counts of articles assessed for eligibility, and, if they satisfied the inclusion criteria, they were included in the meta-analysis.
b This number may have included duplicate records compared to the original search. No new studies reporting primary data were identified
through reviews and similar secondary publications in the updated search, suggesting that the pool of the relevant studies had been
exhausted
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small differences were observed, these did not appear to explain
the variation between studies (Fig. 2b-d).
Per 1000 screens in women with negative mammography,
ultrasound detected on average ca. 4 additional cases of breast
cancer (FE: 3.8, 95% CI: 3.4–4.2; RE: 4.0, 95% CI: 3.1–5.1; as shown in
Fig. 4, this estimate was based on all 23 studies that reported
numbers of screened women with negative mammography). This
was slightly higher, 5 per 1000, in two studies of women with
additional risk factors.12,46 In the 17 studies separating DCIS from
invasive cases, approximately 13% (32/248) were DCIS.
Although for all studies with reported data a large number of
cases were detected by both screening methods (Supplementary
Table 2), there were a considerable number of cases that were
detected by only one method.
Where data were available, there appeared to be no strong and
significant correlation between the number of cancers detected
by mammography and those additionally detected only by
ultrasound, neither when additional detection by ultrasound was
considered in absolute (ρ weighted by number of women in the
study= 0.23, P= 0.62) nor in relative (weighted ρ= –0.48, P=
0.27) terms.
Impact on recall for assessment
Recall for assessment after supplemental ultrasound screening
could be compared to recall after mammography on data from
three studies,12,15,35 two from the USA and one from Sweden.
Here, supplemental ultrasound approximately doubled the
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Fig. 2 Additional detection of breast cancer cases with ultrasound in mammography negative women, compared to the detection with stand-
alone mammography (based on 12 studies reporting detection by both screening modalities). BI-RADS 2 density: breasts with scattered areas of
fibroglandular density (sometimes defined as 25–50% fibroglandular tissue). BI-RADS 3 density: breasts with heterogeneously dense tissue
(50–75%). BI-RADS 4 density: breasts with extremely dense breast tissue (>75%). CI confidence interval, M mammography, US ultrasound (a)
Additional detection, overall results. (b) Additional detection, by definition of breast density. (c) Additional detection, by year of study. (d) Additional



















Fig. 3 Funnel plot of the percentage of cancers detected by
ultrasound against the total number of cancers detected (based on
12 studies reporting detection by both screening modalities)
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studies, the number of biopsies was also doubled,12,35 whereas in
another study,15 it was almost trebled. Both studies from the USA
had an already high mammography abnormality rate, 10%
(BI–RADS 3 to 5)12 and 15% (BI–RADS 0, roughly equivalent to
BI–RADS 4–5 in other studies).15 Interestingly, mammographic
abnormalities were much more infrequent in the Swedish study,
just above 1%,35 which was also lower than the data reported for
the routine screening programme (~3%).51 Another study from
the USA also reported a sharp, 76%, increase in the number of
biopsies.27
Per 1000 mammography negative screens, ultrasound was
positive in 110–130 screens (FE: 131, 95% CI: 128–134; RE: 109,
95% CI: 80–145) when a positive screen was defined as BI–RADS
categories 3–5. Ultrasound would typically prompt a recall for
assessment, defined as BI–RADS categories 4–5, in on average
85 screens per 1000 (FE: 95% CI: 83–88), although this was lower in
smaller studies as evidenced by the RE estimate, 45 per 1000 (95%
CI: 26–75). Approximately 50 per 1000 mammography negative
screens were followed by a recommendation for a biopsy (FE: 47/
RE: 53). Almost all of the women concerned actually had one,
though that was less frequently the case in the smaller studies (FE:
40/FE: 28). All these proportions varied considerably among
studies. Of the 13 studies with reported data, only one included
women with additional risk factors, so the higher-than-average
risk cannot explain the high proportions of women with non-
normal ultrasound findings.
The data did not suggest a relationship between an (increased)
number of women referred for assessment and an (increased)
cancer detection. The correlation between the proportion of
screens with non-normal ultrasound findings (BI–RADS 3–5 or
equivalent) and the extra detected number of cancer cases per
1000 mammography negative screens was weak (ρ weighted by
number of women with negative mammography= 0.25, P= 0.32).
The correlations with the proportions of screens with more
severely abnormal ultrasound findings (BI–RADS 4–5 or equiva-
lent), and of screens followed by a biopsy, were also not
significant (weighted ρ= 0.03 and P= 0.93, and ρ= 0.35 and
P= 0.17, respectively).
Quality of the studies and of their reporting
An evaluation of the quality of the studies and of their reporting
using the QUADAS–2 framework revealed some potential issues
with universal applicability of the findings and a potential for bias
in terms of patient selection and (the interpretation of) the index
tests (Supplementary table 3). These were related to e.g. an
inclusion of women with scattered fibroglandular tissue among
those with “dense” breasts, (retrospective) interpretation of
screening tests with knowledge from other imaging methods,
and exclusion of mammography negative but palpable tumours
after an adjunct clinical breast examination, as this is not a
standard screening procedure in settings such as the UK.
Time investment for ultrasound examinations
The reporting of time spent performing a screening ultrasound
differed by study, so no meta-analysis was undertaken for this
outcome. The time needed for an ultrasound appeared to be
around 10min per woman on average, although the estimates
were highly variable and ranged from mean/median of 5–20
(Supplementary Table 4). Additionally, Hooley and colleagues8
reported that the (routine) ultrasound appointments were
scheduled at 45-min intervals.
DISCUSSION
Main findings
In its latest review from 2016, International Agency for Research
on Cancer (IARC) concluded that there is limited evidence for an
increased detection of breast cancer using supplemental ultra-
sound in women with dense breasts, citing the lack of randomised
controlled trials and study design heterogeneity among the
reasons.4 Our meta-analysis, focusing on the most recent studies,
showed an on average 40% increase in the detection of
asymptomatic breast cancers. Cases missed by mammography
were detected by ultrasound in all but one (underpowered) study.
There are still no data on whether the additional detection by
ultrasound improves mortality from breast cancer, which is in line
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Fig. 4 Extra detection of cases of breast cancer per 1000 women with negative mammography (based on 23 studies reporting detection in
mammographically negative women). CI confidence interval
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only by ultrasound were frequently relatively small, however, the
majority were invasive cancers. Some studies reported interval
cancers, but for the time being those data appear less informative,
as the length of follow-up and the completeness of the
ascertainment differed substantially between studies. In the
future, it would be helpful to see results from a large cohort with
complete ascertainment of interval cancer cases, as this would
give us an estimate of the effect of supplementary ultrasound on
screening programme sensitivity and its ability to reduce breast
cancer mortality.
Clinical implications
Even though in women with dense breasts ultrasound detects
cancers that are missed by mammography (Supplementary
Table 2), ultrasound should be considered as a supplemental
rather than a stand-alone screening method. In studies where all
women underwent both screening tests, roughly 10–30% of all
screen-detected cases were detectable only on mammography.
Currently in England, women 50–70 years of age with dense
breasts are screened with digital mammography every three years,
same as women with fatty breasts. In 2015–2016, 1.8 million
women were screened, with on average 410 women referred for
assessment and 82 having a breast cancer detected per every
10,000.52 This means that about 5 women were referred per
diagnosed cancer case. These statistics are unfortunately not
reported by breast density but the prevalence of at least
heterogeneously dense breasts (BI–RADS 3–4) among screened
women appears to be about 40%.53–58 Women with dense breasts
have roughly twice the risk of breast cancer than those with fatty
breasts,59 and we assume that the risk of an abnormal
mammogram is similarly increased. With these estimates in mind,
it can be approximated that among every 10,000 screened women
4000 have dense breasts (Supplementary Table 5A). Of the 410
referred in total, 234 referrals would be in those with dense
breasts, as would be 47 among the 82 cancers detected with
mammography. Based on our meta-analysis, 3766 ultrasound
examinations in mammography negative women would lead to a
detection of an additional 15–19 cancer cases, of which 2–3 would
be DCIS. The absolute number of additional cancer cases will
depend on the underlying risk in the population but both relative
and absolute meta-analysis results give similar numbers for this
example. This would necessitate an additional 234 referrals
(+100%), or 13–16 per additionally detected cancer case.
Mammography screening of women aged 50–70 years with
supplemental ultrasound for 40% with dense breasts would,
therefore, necessitate 10,000 mammograms, 3766 ultrasound
examinations (lasting, on average, around 10min) and 644
referrals for assessment (57% more than with mammography
alone), and would detect 97–101 breast cancers (18–23% more
than mammography alone).
These calculations suggest that there are important capacity
considerations for an introduction of ultrasound as a supplemen-
tary screening method for women with dense breasts. At present,
ultrasound is used as part of assessment after positive mammo-
graphy, i.e. in 410/10,000 screened women. Hence, the use of
ultrasound in screening for 40% of the target population would
require a ten-fold increase in the ultrasound availability. To lessen
the impact on service providers, supplemental ultrasound screen-
ing could instead be considered for smaller subgroups of women
with a particularly increased risk of breast cancer. As an example,
ultrasound screening could be reserved for the approximately
10% women with extremely dense breasts whose relative risk of
breast cancer is increased approximately threefold compared to
the rest of the population.53,59,60 Assuming the same supple-
mental detection with ultrasound as in the meta analysis, this
strategy would require 898 instead of 3766 ultrasound examina-
tions per 10,000 screened women and a 25% overall increase in
referrals for assessment (an additional 103/10,000). A conservative
estimate of the expected increase in the detection rate, based on
the average effect found in our meta-analysis, would be in the
order of 10% (an additional 8/10,000; Supplementary Table 5B).
From the above calculations, it is evident that although the
addition of ultrasound would increase the number of assessments,
the major call on resources would be the performance of the
ultrasound examinations. This could potentially be kept to a
manageable level by use of a high density threshold.
At present, 31 women per 10,000 screened have an interval
breast cancer diagnosed after negative mammography.61 It is
likely that supplementary ultrasound could help decrease this risk
by detecting cancers already at screening, but it is not yet clear by
how much because the extent of overdiagnosis for now remains
uncertain. Assuming that, like in mammography,62 also here
overdiagnosis can explain only a small proportion of cases, the
additional detection by supplementary ultrasound (estimated
above at 19 or 8 per 10,000), could prove to be clinically
meaningful in decreasing the overall interval cancer rate.
Strengths and weaknesses
We did a thorough systematic search in the leading medical
database, and, additionally, hand-searched all identified reviews
and similar secondary literature. We used pre-specified selection
criteria and excluded studies that did not describe routine
screening settings.
Although none of the studies was a randomised trial, both
mammography and ultrasound testing in the selected studies
were undertaken sequentially in the same women. This means
that all women acted as their own controls, thereby accounting for
between-patient variability. However, we cannot exclude a
potential study effect on mammography interpretation particu-
larly in the more complex cases, originating from the radiologists
being aware that ultrasound will form part of the screening
evaluation.
Nevertheless, several studies identified in our search had to be
excluded from the review as they did not report the data
separately for asymptomatic women undergoing screening, or by
their breast density. This suggests that a substantial amount of the
relevant data may have remained unreported, however, funnel
plot analysis suggested only a small effect of a publication bias.
Although all studies described asymptomatic women, there
were important differences in their study designs. First, while most
studies defined dense breasts as those with at least hetero-
geneous density (≥50% fibroglandular tissue), a handful of studies
reported data for women with at least scattered density (25–49%
fibroglandular tissue) where the risk of breast cancer is generally
lower59 and mammography tends to be more sensitive.63 The
inclusion of women with scattered density appears to have
slightly diluted the beneficial effect of the ultrasound (proportion
of cancers detected by ultrasound 0.23 with BI–RADS 2-4 vs. 0.31
with BI–RADS 3–4). Second, intensive additional imaging, includ-
ing not just ultrasound but also e.g. magnetic resonance, may be a
sensible option for women with additional risk factors such as
those who are BRCA 1/2 gene carriers or have a high estimated
lifetime risk of breast cancer.64 The inclusion of studies focusing
only on women with additional risk factors did not seem to
substantially alter our results (proportion of cancers detected by
ultrasound with additional risk factors 0.29 vs. 0.33 when women
were not selected based on additional risk factors). It should be
noted, however, that at least a small proportion of high-risk
women were included in virtually all studies. Third, older studies
used film-screen mammography, which was shown in some
studies to be less sensitive in dense breasts than digital
mammography.55 Adding ultrasound appeared to be slightly
more beneficial after film-screen mammography (proportion of
cancers detected by ultrasound 0.31 vs. 0.25 in digital mammo-
graphy). Multiple studies are now underway to further improve
the detection of breast cancer with mammography. An example of
Ultrasound screening for women with dense breasts
M Rebolj et al.
10
new mammography-based technologies is supplemental tomo-
synthesis, which appears to significantly improve the overall
detection of breast cancer,65 including that among women with
dense breasts.66 Only two studies used the newer automated
ultrasound technology;15,35 in both studies, the extra detection
was close to the pooled estimate. Ultrasound screening was
undertaken by radiographers in one large study using hand-held
devices.26 The additional detection of breast cancer was slightly
lower in this study than in the pooled estimate, suggesting that,
for radiologist-operated and radiologist-read hand-held ultra-
sound screening, the pooled estimate is on the conservative side.
Another factor that may have affected the comparisons between
the studies is the proportion of studied women undergoing
prevalence (first) and incidence (any subsequent) screening
rounds. In mammography screening, breast cancer detection
and the frequency of referral for assessment are both lower in the
incidence rounds.52 The same trend was suggested for ultrasound
screening in the study by Berg and colleagues,12 where ultrasound
detected 70% more cases than mammography in the prevalence
round (14 only by ultrasound vs. 20 by mammography), and
thereafter 56% (9 vs. 16) and 39% (9 vs. 23) more cases in the first
and the second incidence rounds, respectively. The frequency of
positive ultrasound examinations without an underlying cancer
about halved from the prevalence to the incidence rounds, with
16% and 8%, respectively. A more detailed reporting of the
outcomes by screening round from other studies would be
informative. Additionally, BI-RADS density classification has
changed over time, with the latest edition published in 2013
effectively lowering the threshold for classifying breasts as
dense.67 Finally, the studies differed in the degree to which
ultrasound image interpretation could be influenced by knowl-
edge of mammography imaging and vice versa (although this
detail was not consistently reported), and in how they selected
their study populations, e.g. by whether screening was organised
or opportunistic. All these factors may have led to slightly different
selections of women in terms of their risk profile, and this
heterogeneity needs to be taken into account in the interpretation
of the results.
CONCLUSION
Studies have consistently shown an increased detection by
supplementary ultrasound of predominantly small but invasive
breast cancers in women with dense breasts. The feasibility of this
screening method in routine practice might be at present limited
given its resource use, although the strain on the health care
capacities might be manageable by a careful targeting of the
highest-risk women among those with dense breasts.
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